MOTS-C 10mg

What is MOTS-C?

MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c) represents one of the most paradigm-shifting discoveries in modern cell biology. Identified in 2015 by Dr. Changhan Lee and colleagues at the University of Southern California, this 16-amino acid peptide revealed something remarkable: the mitochondrial genome—long believed to encode only 13 structural proteins for the electron transport chain—contains open reading frames for bioactive signaling peptides that directly regulate nuclear gene expression. MOTS-c was the first mitochondrial-derived peptide shown to translocate to the nucleus and modulate transcription, establishing an entirely new category of retrograde mitochondrial-nuclear signaling.

During metabolic stress—such as glucose deprivation, exercise, or caloric restriction—MOTS-c translocates from the cytoplasm to the nucleus, where it interacts with transcription factors and stress-responsive promoter regions to upregulate genes involved in glucose metabolism, insulin sensitivity, and metabolic adaptation. This mitochondrial-to-nuclear communication represents a feedback loop whereby mitochondria inform the nucleus of their metabolic status, enabling coordinated cellular adaptation to energy challenges.

The peptide activates AMP-activated protein kinase (AMPK)—the master metabolic sensor—through modulation of the folate-methionine cycle and de novo purine biosynthesis. AMPK activation triggers a cascade of metabolic adaptations including enhanced glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. Critically, endogenous MOTS-c levels decline with age across multiple tissues, correlating with metabolic dysfunction and insulin resistance—positioning it at the intersection of aging research, metabolic disease, and mitochondrial biology.

Mechanism of Action

MOTS-c operates as a retrograde mitochondrial signaling molecule that coordinates nuclear gene expression with mitochondrial metabolic status. Under basal conditions, the peptide resides primarily in the cytoplasm. Upon metabolic stress—glucose deprivation, exercise, or cellular energy depletion—MOTS-c undergoes nuclear translocation, where it interacts with antioxidant response elements (ARE) in gene promoter regions, binding alongside transcription factors Nrf2 and ATF-1 to upregulate stress-responsive metabolic genes.

The peptide's metabolic effects center on AMPK activation through an elegant mechanism: MOTS-c inhibits the folate-methionine cycle enzyme MTHFD2, reducing de novo purine biosynthesis and accumulating the AMPK-activating metabolite AICAR (5-aminoimidazole-4-carboxamide ribonucleotide). This indirect AMPK activation triggers downstream metabolic cascades including GLUT4 translocation to the plasma membrane (enhancing glucose uptake in skeletal muscle by up to 50%), increased fatty acid β-oxidation through ACC phosphorylation, and stimulation of mitochondrial biogenesis via PGC-1α activation.

Beyond metabolic regulation, MOTS-c demonstrates exercise-mimetic properties: it activates the same AMPK-dependent signaling pathways engaged during physical exercise, including enhanced mitochondrial function, improved insulin sensitivity, and reduced inflammatory signaling. Its age-dependent decline—with levels dropping by approximately 30-50% between youth and old age—suggests it may serve as both a biomarker of mitochondrial health and a mechanistic link between mitochondrial dysfunction and age-related metabolic disease.

Nuclear Translocation and Transcriptomic Effects

The nuclear translocation of MOTS-c represents a conceptually revolutionary finding in mitochondrial biology. Prior to MOTS-c's discovery, retrograde mitochondrial signaling was thought to operate exclusively through metabolites (reactive oxygen species, calcium, NAD+/NADH ratio) and cytoplasmic protein intermediates. MOTS-c demonstrated that mitochondria-encoded peptides can directly enter the nucleus and interact with chromatin—establishing a previously unknown communication channel between these two DNA-containing organelles.

Upon nuclear entry, MOTS-c interacts with antioxidant response elements (ARE) in promoter regions of metabolic genes. Chromatin immunoprecipitation studies reveal MOTS-c binding to promoters of genes encoding glucose transporters (GLUT4), fatty acid oxidation enzymes (CPT1A, ACADL), and mitochondrial biogenesis regulators (TFAM, NRF1). This transcriptomic reprogramming shifts cellular metabolism toward enhanced glucose utilization and fat oxidation—metabolic adaptations remarkably similar to those produced by endurance exercise training.

The exercise-mimetic properties of MOTS-c are further supported by its release kinetics. During exercise, MOTS-c is secreted from contracting skeletal muscle into the circulation, where it acts as a "mitokine"—a mitochondria-derived signaling factor that communicates metabolic status to distant organs. Circulating MOTS-c levels increase acutely during exercise and decline with sedentary aging, suggesting the peptide may mediate some of exercise's systemic metabolic benefits. This positions MOTS-c research at the intersection of exercise physiology, aging biology, and mitochondrial medicine—a convergence of fields that is reshaping our understanding of metabolic health.

Key Research Findings

• Enhances insulin sensitivity and glucose metabolism through AMPK activation, promoting metabolic adaptation comparable to exercise training in sedentary models (Lee et al., Cell Metab, 2015; PMID: 25738459)
• Demonstrates age-dependent decline in endogenous levels across skeletal muscle, brain, and circulating plasma, with supplementation reversing metabolic dysfunction in aged mice (Kim et al., J Am Geriatr Soc, 2023)
• Regulates folate-methionine cycle activity through MTHFD2 inhibition, accumulating AICAR to activate AMPK independently of AMP:ATP ratio changes (Lee et al., Cell Metab, 2015)
• Nuclear translocation under metabolic stress coordinates expression of >100 stress-responsive genes through interaction with ARE promoter elements (Kim et al., Cell Metab, 2018)
• Improves skeletal muscle insulin sensitivity by 40% in diet-induced obese mice through enhanced GLUT4 translocation and glucose disposal (Reynolds et al., Aging Cell, 2021)
• Exercise-induced MOTS-c release from skeletal muscle acts as a mitokine, signaling to distant tissues and improving systemic metabolic parameters (Reynolds et al., 2021)

Research Applications

• Mitochondrial-nuclear retrograde signaling pathway characterization
• AMPK activation mechanisms and metabolic sensor biology
• Insulin sensitivity and glucose uptake research in skeletal muscle
• Mitochondrial-derived peptide (MDP) biology and genomics
• Exercise mimetic compound research and metabolic adaptation
• Aging-related metabolic decline and mitochondrial dysfunction
• Folate-methionine cycle regulation and purine metabolism

Published Research Protocols

Published protocols describe reconstitution with bacteriostatic water. MOTS-c dissolves readily in aqueous solution. Published in vivo protocols typically use 5-15 mg/kg in rodent models, administered intraperitoneally. In vitro studies use 1-10 μM for metabolic flux assays and AMPK activation measurements.

Storage & Handling

Store lyophilized at -20°C protected from moisture. Published protocols describe reconstitution with bacteriostatic water; stable at 2-8°C for 30 days. Handle as a standard peptide despite its mitochondrial origin. Published handling protocols advise against repeated freeze-thaw cycles which may reduce bioactivity.

Clinical and Translational Significance

MOTS-c research has expanded rapidly from basic mitochondrial biology into translational applications. Population studies have revealed that specific MOTS-c polymorphisms (particularly m.1382A>C in the 12S rRNA gene) are associated with longevity in Japanese centenarians, while reduced circulating MOTS-c levels correlate with type 2 diabetes, obesity, and cardiovascular disease risk in multiple cohorts. These epidemiological findings, combined with the robust preclinical data demonstrating metabolic benefits of MOTS-c supplementation, have positioned this peptide at the forefront of translational aging research.

The peptide's role in exercise adaptation provides another rich research avenue. MOTS-c is released from contracting skeletal muscle in proportion to exercise intensity, with levels peaking during high-intensity interval training. This exercise-induced release functions as a systemic signal that coordinates metabolic adaptation across multiple organs: enhancing hepatic glucose output during exercise, promoting fatty acid mobilization from adipose tissue, and improving skeletal muscle insulin sensitivity during recovery. Researchers investigating the molecular mechanisms of exercise benefits—and developing exercise-mimetic interventions for populations unable to exercise—find MOTS-c an essential investigational tool.

The broader implications of MOTS-c's discovery extend to our understanding of the mitochondrial genome itself. If mitochondria encode bioactive signaling peptides beyond their known 13 structural proteins, other mitochondrial-derived peptides (MDPs) likely remain undiscovered. Indeed, since MOTS-c's characterization, additional MDPs including humanin and SHLP1-6 have been identified, each with distinct biological activities. MOTS-c research thus serves as a gateway to an entirely new dimension of mitochondrial biology with potentially transformative implications for metabolic medicine.